HS
HighVista Strategies’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Sell |
26,324
-52,096
| -66% | -$496K | 0.09% | 141 |
|
|
2025
Q1 | $820K | Hold |
78,420
| – | – | 0.32% | 116 |
|
|
2024
Q4 | $1.85M | Buy |
78,420
+12,938
| +20% | +$305K | 0.69% | 47 |
|
|
2024
Q3 | $2.35M | Buy |
+65,482
| New | +$2.35M | 0.81% | 37 |
|
|
2023
Q2 | – | Sell |
-102,431
| Closed | -$1.18M | – | 141 |
|
|
2023
Q1 | $1.18M | Hold |
102,431
| – | – | 0.96% | 30 |
|
|
2022
Q4 | $1.19M | Hold |
102,431
| – | – | 0.7% | 37 |
|
|
2022
Q3 | $1.3M | Sell |
102,431
-139,436
| -58% | -$1.77M | 0.74% | 37 |
|
|
2022
Q2 | $1.66M | Buy |
241,867
+73,176
| +43% | +$503K | 1% | 32 |
|
|
2022
Q1 | $1.63M | Buy |
+168,691
| New | +$1.63M | 1.03% | 26 |
|
|
2021
Q1 | – | Sell |
-23,760
| Closed | -$499K | – | 131 |
|
|
2020
Q4 | $499K | Buy |
+23,760
| New | +$499K | 0.32% | 67 |
|